Developing compact MRI technology to improve accessibility worldwide
Breakthrough Technology to Expedite the Democratization of High Field MRI
This study is working on a new, smaller MRI machine that uses less powerful magnets to make MRI scans easier to get, especially in places where medical resources are limited, while also improving the quality of the images and keeping costs down.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11124390 on NIH RePORTER |
What this research studies
This research focuses on creating a new type of compact magnetic resonance imaging (MRI) system that operates at mid-field strength (0.7 Tesla) to make MRI more accessible, especially in remote and resource-limited areas. The project aims to eliminate the need for large and expensive hardware components traditionally used in MRI systems, thereby reducing costs and increasing portability. By utilizing innovative technology called Frequency-modulated Rabi-Encoded Echoes, the research seeks to enhance the quality of MRI images while making them more affordable and easier to deploy in various settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in remote or resource-limited areas who require MRI imaging for diagnosis or monitoring of health conditions.
Not a fit: Patients who already have access to high-quality MRI facilities and do not face barriers to imaging services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase access to high-quality MRI imaging for patients in underserved regions, improving diagnosis and treatment options.
How similar studies have performed: Other research has shown promise in developing portable MRI technologies, but this specific approach using Frequency-modulated Rabi-Encoded Echoes is relatively novel.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Garwood, Michael — University of Minnesota
- Study coordinator: Garwood, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.